Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent).

Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent).

Item
http://www.wikidata.org/entity/Q43074205
Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected.Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.Extension of Kaplan-Meier methods in observational studies with time-varying treatment.Perioperative clopidogrel and postoperative events after hip and knee arthroplasties.Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent RegistryLong-term safety of drug-eluting stents.Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program.Optimal duration of dual-antiplatelet therapy following drug-eluting stent implantation: a meta-analysis.Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation
P2860

Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent).

Item
http://www.wikidata.org/entity/Q43074205
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Increased risk of bleeding in ...... -Stent Registry (HMORN-stent).
@en
Increased risk of bleeding in ...... esearch Network-Stent Registry
@nl
type
label
Increased risk of bleeding in ...... -Stent Registry (HMORN-stent).
@en
Increased risk of bleeding in ...... esearch Network-Stent Registry
@nl
prefLabel
Increased risk of bleeding in ...... -Stent Registry (HMORN-stent).
@en
Increased risk of bleeding in ...... esearch Network-Stent Registry
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Increased risk of bleeding in ...... k-Stent Registry (HMORN-stent)
@en
P2093
P304
P31
P356
10.1161/CIRCINTERVENTIONS.109.919001
P433
P478
P50
P577
P698
P921